2021
DOI: 10.2478/jccm-2021-0020
|View full text |Cite
|
Sign up to set email alerts
|

Critical Care Management of Decompensated Right Heart Failure in Pulmonary Arterial Hypertension Patients – An Ongoing Approach

Abstract: Despite substantial advancements in diagnosis and specific medical therapy in pulmonary arterial hypertension patients’ management, this condition continues to represent a major cause of mortality worldwide. In pulmonary arterial hypertension, the continuous increase of pulmonary vascular resistance and rapid development of right heart failure determine a poor prognosis. Against targeted therapy, patients inexorable deteriorate over time. Pulmonary arterial hypertension patients with acute right heart failure … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(11 citation statements)
references
References 97 publications
0
4
0
Order By: Relevance
“…The rapid onset (15 minutes), peak effects (60 minutes) and a 4-6 hour onset of action of Sildenafil increase of cardiac output and RV contractility, decrease of mPAP and PVR. [27][28][29] Sildenafil recommendations according to WHO functional class II-III is IA. 30 Diuretics are used in volume management in patients with PAH is the several classes.…”
Section: Discussionmentioning
confidence: 99%
“…The rapid onset (15 minutes), peak effects (60 minutes) and a 4-6 hour onset of action of Sildenafil increase of cardiac output and RV contractility, decrease of mPAP and PVR. [27][28][29] Sildenafil recommendations according to WHO functional class II-III is IA. 30 Diuretics are used in volume management in patients with PAH is the several classes.…”
Section: Discussionmentioning
confidence: 99%
“…PACs may be useful adjuncts to guide fluid management and titrate vasoactive medications in selective high-risk patients when significant hemodynamic disturbances are expected; however, their utility has been debated (Wanner and Filipovic 2020 ). Monitoring trends in CVP, pulmonary artery pressure (PAP), CO, and mixed venous oxygen saturation (SvO 2 ) can provide useful feedback, but interpretation requires a thorough understanding (Tilea et al 2021 ; Marik 2013 ).…”
Section: Methodsmentioning
confidence: 99%
“…Bradyarrhythmias and ventricular arrhythmias are rare in patients with RV failure, except in cases of cardiac arrest [4]. The development of SVT is considered a negative prognostic marker in ARHF and is associated with right ventricular failure and increased mortality [37]. Patients with atrial tachyarrhythmias may benefit from electrical cardioversion, as the dysrhythmia can lead to worsening right ventricular cardiac output due to the loss of atrial kick [17], although large-scale studies on its use have yet to be studied in RV failure [4].…”
Section: Anti-arrhythmicsmentioning
confidence: 99%
“…Patients with atrial tachyarrhythmias may benefit from electrical cardioversion, as the dysrhythmia can lead to worsening right ventricular cardiac output due to the loss of atrial kick [17], although large-scale studies on its use have yet to be studied in RV failure [4]. Amiodarone and digoxin are the leading choices for the restoration of sinus rhythm [34,37]. Radiofrequency ablation is another option for patients with recurrent SVT [1].…”
Section: Anti-arrhythmicsmentioning
confidence: 99%